Company · CIK 1811063
Nuvation Bio Inc.
| CIK | 1811063 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | NUVB (NYSE) |
| First annual or quarterly report | 2020-08-14 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-285621 | 2025-03-06 | 2026-06-29 | 3 | |
| 333-281255 | 2024-08-05 | 2024-08-15 | 2 | |
| 333-254176 | 2021-03-11 | 2022-04-07 | 5 | |
| 333-239138 | 2020-06-12 | 2020-07-02 | 4 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-29 | 424B5Shelf takedown | 333-285621 | 0001193125-26-286494 |
| 2026-06-25 | 424B5Shelf takedown | 333-285621 | 0001193125-26-281815 |
| 2025-03-06 | S-3ASRShelf registered | 333-285621 | 0001193125-25-048571 |
| 2024-08-15 | EFFECTDeclared effective | 333-281255 | 9999999995-24-002545 |
| 2024-08-05 | S-3Shelf registered | 333-281255 | 0001193125-24-194000 |
| 2022-04-07 | EFFECTDeclared effective | 333-254176 | 9999999995-22-000854 |
| 2021-05-28 | EFFECTDeclared effective | 333-254176 | 9999999995-21-002155 |
| 2021-03-31 | EFFECTDeclared effective | 333-254176 | 9999999995-21-001232 |
| 2021-03-29 | S-1/AAmendment | 333-254176 | 0001193125-21-098442 |
| 2021-03-11 | S-1Registration filed | 333-254176 | 0001193125-21-077946 |
| 2021-01-20 | EFFECTDeclared effective | 333-250036 | 9999999995-21-000199 |
| 2020-07-02 | 424B4Final prospectus | 333-239138 | 0001213900-20-016518 |
| 2020-06-30 | EFFECTDeclared effective | 333-239138 | 9999999995-20-001688 |
| 2020-06-23 | S-1/AAmendment | 333-239138 | 0001213900-20-015592 |
| 2020-06-12 | S-1Registration filed | 333-239138 | 0001213900-20-014829 |
| 2020-05-15 | DRSDraft made public | 377-03174 | 0001213900-20-012618 |